TK CHEMICAL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,651 KRW | +1.60% |
|
+4.30% | -7.30% |
| 2021 | TK Chemical Corporation(KOSDAQ:A104480) added to S&P Global BMI Index | CI |
| 2019 | E&H Co., Ltd. announced that it has received KRW 14 billion in funding from TK Chemical Corporation | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Capitalization 1 | 2,51,780 | 1,90,976 | 2,18,997 | 5,16,286 |
| Enterprise Value (EV) 1 | 4,89,247 | 4,68,442 | 4,72,805 | 7,30,612 |
| P/E ratio | 8.44 x | 20.1 x | -162 x | 1.45 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 0.32 x | 0.31 x | 0.51 x | 0.74 x |
| EV / Revenue | 0.62 x | 0.75 x | 1.1 x | 1.05 x |
| EV / EBITDA | 7.49 x | 22.5 x | -52.3 x | 9.65 x |
| EV / FCF | - | -2,08,18,596 x | 1,39,66,828 x | 4,05,83,791 x |
| FCF Yield | - | -0% | 0% | 0% |
| Price to Book | 0.92 x | 0.7 x | 0.82 x | 0.77 x |
| Nbr of stocks (in thousands) | 90,895 | 86,219 | 86,219 | 90,895 |
| Reference price 2 | 2,770 | 2,215 | 2,540 | 5,680 |
| Announcement Date | 16/03/20 | 16/03/20 | 23/03/21 | 23/03/22 |
1KRW in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net sales 1 | 7,89,034 | 6,20,804 | 4,29,303 | 6,93,903 |
| EBITDA 1 | 65,292 | 20,850 | -9,035 | 75,696 |
| EBIT 1 | 54,544 | 9,636 | -21,006 | 66,516 |
| Operating Margin | 6.91% | 1.55% | -4.89% | 9.59% |
| Earnings before Tax (EBT) 1 | 38,006 | 10,572 | 961.3 | 4,20,952 |
| Net income 1 | 28,284 | 9,492 | -1,355 | 3,50,833 |
| Net margin | 3.58% | 1.53% | -0.32% | 50.56% |
| EPS 2 | 328.1 | 110.1 | -15.72 | 3,921 |
| Free Cash Flow | - | -22,501 | 33,852 | 18,003 |
| FCF margin | - | -3.62% | 7.89% | 2.59% |
| FCF Conversion (EBITDA) | - | - | - | 23.78% |
| FCF Conversion (Net income) | - | - | - | 5.13% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 16/03/20 | 16/03/20 | 23/03/21 | 23/03/22 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net Debt 1 | 2,37,467 | 2,77,466 | 2,53,807 | 2,14,326 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.637 x | 13.31 x | -28.09 x | 2.831 x |
| Free Cash Flow | - | -22,501 | 33,852 | 18,003 |
| ROE (net income / shareholders' equity) | - | 3.57% | -0.5% | 75% |
| ROA (Net income/ Total Assets) | - | 0.88% | -1.93% | 4.55% |
| Assets 1 | - | 10,74,478 | 70,157 | 77,11,965 |
| Book Value Per Share 2 | 3,011 | 3,151 | 3,099 | 7,347 |
| Cash Flow per Share 2 | 80.80 | 100.0 | 188.0 | 138.0 |
| Capex 1 | 4,878 | 12,568 | 5,452 | 3,758 |
| Capex / Sales | 0.62% | 2.02% | 1.27% | 0.54% |
| Announcement Date | 16/03/20 | 16/03/20 | 23/03/21 | 23/03/22 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.30% | 110M | |
| +32.96% | 7.24B | |
| -4.24% | 1.33B | |
| +16.84% | 1.17B | |
| +8.84% | 1.06B | |
| +11.08% | 896M | |
| +6.46% | 767M | |
| +0.75% | 598M | |
| -19.53% | 549M | |
| +8.22% | 557M |
- Stock Market
- Equities
- A104480 Stock
- Financials TK Chemical Corporation